Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.

In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...

When introduced with a new immunosuppressant treatment, people with systemic lupus erythematosus (SLE) typically see clinical improvement of extrarenal flares within 6 months. A new study published in ...

More than 50% of patients with systemic lupus erythematosus (SLE) experienced flare and nearly 50% had persistently active disease, whereas some had persistently active disease without flare. Both ...

Please provide your email address to receive an email when new articles are posted on . 38% of patients with cutaneous lupus erythematosus displayed evidence of positive interferon (IFN)-alpha ...

Intercurrent infections are associated with an increased risk for systemic lupus erythematosus (SLE) flares within 3 months, with major infections associated with a 7.4 times higher risk for major ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Please provide your email address to receive an email when new articles are posted on . Early mycophenolate mofetil in newly diagnosed SLE led to fewer severe flares and lower incidence of lupus ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for increasing ...